stockrow
Friday 6 November 2026
Export OMDA’s income statement to Excel — free account
Omada Health, Inc.
OMDA Healthcare Health Information Services
Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
- Revenue
- +34.2%
- EPS
- +283.3%
- Free cash flow
- +65.8%
Quarter to September 2026, against a year earlier
15.10
3.85
−20.32%
Follow OMDA
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 5.72% | 1.84% | 8.38% | 0.00% |
+7 more TTM periods Free account |
|
| 4.41% | 1.36% | (4.16%) | (8.37%) | ||
ROIC |
14.34% | (0.93%) | (23.37%) | (97.89%) | |
Return on Tangible Assets |
5.63% | 1.88% | (3.01%) | (6.23%) | |
Average Days of Receivables |
52.82 | 66.66 | 51.52 | 48.51 | |
Free Cash Flow per Share |
0.37 | 0.29 | 0.28 | 0.34 | |
Free Cash Flow |
22.49 | 17.13 | 16.40 | 12.42 | |
Capital Expenditures |
(6.20) | (6.55) | (6.14) | (5.83) | |
| Other line items | |||||
Cash ROIC |
4.36% | 3.61% | 3.68% | 2.75% | |
Accounts Receivable Turnover |
7.43 | 6.89 | 8.94 | 0.00 | |
Accounts Payable Turnover |
14.22 | 10.26 | 15.58 | 0.00 | |
Inventory Turnover |
24.32 | 25.97 | 26.82 | 0.00 | |
Average Days of Payables |
31.35 | 43.72 | 30.94 | 42.02 | |
Days of Inventory on Hand |
18.25 | 15.26 | 14.63 | 18.34 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.26% | 15.88% | 15.73% | 15.63% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 52.46% | 53.48% | 54.66% | |
Share Based Compensation of Revenue |
5.84% | 5.53% | 5.05% | 4.98% | |
Interest Coverage |
22.37 | (1.17) | (5.65) | (4.72) | |
Operating CF/Net income |
2.04 | 5.50 | (3.58) | (1.43) | |
Depreciation/Fixed assets |
0.00 | 1.06 | 1.11 | 1.15 | |
Capex/Depreciation |
0.00 | (0.68) | (0.65) | (0.64) | |
Revenue per Share |
5.42 | 5.19 | 4.81 | 7.10 | |
Operating CF per Share |
0.47 | 0.40 | 0.38 | 0.50 | |
Capex per Share |
(0.10) | (0.11) | (0.10) | (0.16) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026